Pinsent Masons ramps up for Bribery Act 2010

17 Dec 2010 | 12:00 am | 1 min. read

International law firm Pinsent Masons has recently enhanced its regulatory and business crime practice with the appointment of Neil McInnes and Benjamin Long, two specialist criminal fraud lawyers with expertise in business crime investigations and prosecutions.

The appointments come at a point when corporate criminal liability is high on the boardroom agenda, with the coming in to force of the Bribery Act due in April 2011, and the importance for businesses to have adequate procedures in place to prevent corruption.

Neil McInnes, a Senior Associate and barrister, and Benjamin Long, a barrister, are based in London and report to Dr Simon Joyston-Bechal, head of Pinsent Masons' national Corporate Defence and Regulatory team.

Neil (called to the Bar 1999) joins from the criminal department of Bindmans LLP in London. He has particular expertise in tax fraud, bribery and corruption, market-related offences and money laundering investigations.

Benjamin (called to the Bar in 2006) arrives from Furnival Chambers and specialises in white-collar crime and asset forfeiture, in particular corruption and bribery, money laundering and confiscation.

Together Neil and Benjamin will assist the firm to develop a full service business crime practice, working with existing specialists in the Financial Services, Competition and Health & Safety teams, amongst others across the firm internationally.

Dr Simon Joyston-Bechal, commented:

"We are delighted to welcome Neil and Benjamin to our Regulatory and Disputes team. Their appointments significantly enhance our offering to clients across a range of business crime areas. Companies and their directors increasingly find themselves in need of specialist advice from criminal lawyers, with insight and direct experience of regulatory investigations and prosecutions. We are excited that Neil and Benjamin can strengthen our existing capabilities across these areas. Their appointments come at a particularly important juncture with the introduction of the Bribery Act 2010, and the need for corporates to obtain specialist advice on their risk exposure and put in place adequate procedures to prevent corruption."

Latest press releases

Show me all press releases

Pinsent Masons advises Supervisory Board of Telefónica Deutschland on successful delisting tender offer

Multinational law firm Pinsent Masons has advised the Supervisory Board of Telefónica Deutschland on the delisting tender offer of Telefónica Local Services GmbH, a subsidiary of Telefónica, S.A.

Pinsent Masons hires senior litigation and investigations partner Melanie Ryan in London

Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises Bestinver Infra, FCR on acquisition of remaining shares in Irish toll road concession & operation companies

Pinsent Masons has advised Bestinver Infra, FCR on the acquisition of the remaining shares in N6 (Concession) Holdings Limited and N6 (Operations) Ltd, with Japanese co-investor Daiwa Energy & Infrastructure Co. Ltd.

Pinsent Masons advises Sandoz on acquisition of remaining shares in Rowex Joint Venture

Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.